Citi initiates Nuvation Bio coverage with Buy rating, $12 target
Tweet Send to a Friend
(Updated - September 30, 2026 5:05 AM EDT)
Citi analyst Geoff initiated coverage of Nuvation Bio Inc (NYSE: NUVB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst Geoff initiated coverage of Nuvation Bio Inc (NYSE: NUVB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
